Speed, Scrutiny, and Spending: How Washington Is Reshaping the Future of Medicine
Washington is navigating a period of significant change in health policy, with implications for how new medicines are developed, reviewed, and paid for.
In this episode of Making Medicine, we take a closer look at several recent developments shaping the life sciences landscape. We discuss the FDA’s new priority review voucher pilot and the debate around how the agency can balance speed, scientific rigor, and public trust as it works to accelerate patient access to therapies.
We also break down new reforms aimed at increasing transparency in Medicare Part D and reining in pharmacy benefit…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.